Merz Pharma GmbH & Co. KGaA (manufacturing of unpackaged product, in-process quality control testing, cell-based assay, quantitative determination of Botulinum neurotoxin Clostridium Botulinum type A (ELISA), primary packaging; secondary packaging, batch release)

The drug is used for the temporary reduction of facial wrinkles (between the eyebrows, around the eyes, and on the forehead) in adults up to 65 years of age. It is also prescribed for the treatment of blepharospasm, cervical dystonia, and muscle spasticity in the arm.

Dosage form: powder for injection solution

ATC: M03AX01